Počet záznamov: 1
SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy
- SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy / G. Shen ... [et al.]. Neoplasma Vol. 59, no. 5 (2012), s. 486-493
článok
Počet záznamov: 1